Literature DB >> 6389252

Ribonucleotide reductase and thymidine kinase activities in various cultured cell lines derived from hematologic malignancies.

E Takeda, M Hirose, Y Kuroda, T Ninomiya, K Toshima, T Watanabe, M Ito, E Naito, M Miyao.   

Abstract

The activities of ribonucleotide reductase and thymidine kinase, and the thymidine incorporation rate were measured in 16 cultured human hematologic malignant cell lines with different cell proliferation rates. Thymidine kinase activity was significantly higher in myeloid and monocytoid cell lines than in other cell lines, but ribonucleotide reductase activity presented as CDP reductase activity was similar in the different cell lines. The ratio of thymidine kinase to CDP reductase activity was high in monocytoid cell lines. A close correlation was found between the cell proliferation rate and CDP reductase activity, but not thymidine kinase activity or the thymidine incorporation rate. The ratio of thymidine kinase to CDP reductase activity was high in slowly growing cell lines and low in rapidly growing cell lines. These results indicate that in cultured human malignant cells a high potential for proliferation may depend mainly on the de novo pyrimidine pathway of DNA biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389252

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  5 in total

1.  A study of deoxyribonucleotide metabolism and its relation to DNA synthesis. Supercomputer simulation and model-system analysis.

Authors:  F Heinmets; R H Leary
Journal:  Cell Biophys       Date:  1991-06

2.  Supercomputer analysis of purine and pyrimidine metabolism leading to DNA synthesis.

Authors:  F Heinmets
Journal:  Cell Biophys       Date:  1989-06

3.  Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes.

Authors:  M Oblender; U Carpentieri
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.

Authors:  E Takeda; Y Kuroda; E Naito; I Yokota; T Saijo; M Hirose; M Miyao
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.

Authors:  M Hirose; E Takeda; T Ninomiya; Y Kuroda; M Miyao
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.